Volume 14, Issue 7 pp. e390-e393
Original article

Thrombo-prophylaxis in colorectal surgery: a National Questionnaire Survey of the members of the Association of Coloproctology of Great Britain and Ireland

N. Srinivasaiah

N. Srinivasaiah

Specialty Trainee in General Surgery, London Deanery, London, UK

Search for more papers by this author
R. Arsalani-Zadeh

R. Arsalani-Zadeh

Specialty Trainee in General Surgery, Northwest Deanery, Liverpool, UK

Search for more papers by this author
J. R. Monson

J. R. Monson

Chief, Division of Colorectal Surgery, University of Rochester, Rochester, New York, USA

Search for more papers by this author
First published: 09 February 2012
Citations: 15
Narasimhaiah Srinivasaiah, Flat 3, Belle Vue court, Belle Vue gardens, Brighton BN2 0AN, UK.
E-mail: [email protected]

Abstract

Aim  Available guidelines from the National Institute for Health and Clinical Excellence (NICE) and the Association of Coloproctology of Great Britain and Ireland (ACPGBI) recommend combined (medical + mechanical) thrombo- prophylaxis. A Cochrane Library review recommends self-administered low-molecular-weight heparin (LMWH) for 2–3 weeks following surgery. In the light of the recent guidelines from the ACPGBI and NICE, we undertook a National Questionnaire Survey to assess current thrombo-prophylaxis practice among colorectal surgeons in the UK.

Method  A 10-item questionnaire was designed to enquire into the current management strategy of postoperative thrombo-prophylaxis. The postal questionnaire survey was sent to all 490 active consultant members of the ACPGBI.

Results  Of the 490 questionnaires sent, 259 (52.8%) were returned fully completed. Among these, all (100%) respondents reported the routine use of thrombo-prophylaxis, with 243 (93.8%) following departmental guidelines. Combined medical and mechanical prophylaxis was used by 247 (95.40%) respondents. A small number – 12 (4.6%) – used medical prophylaxis only. LMWH was the preferred medical-prophylactic agent of 243 (93.8%) repondents. The majority, 176 (68%), started thrombo-prophylaxis on admission and stopped it at discharge. Seventy-one (27.4%) respondents recommended thrombo-prophylaxis after hospital discharge for an average duration of 4–6 weeks, preferring graduated compression stockings followed by LMWH.

Conclusion  The National Questionnaire Survey on thrombo-prophylaxis demonstrated a high degree of concordance with the available guidelines, except for thrombo-prophylaxis to be continued postoperatively for a period of 28 days/4 weeks.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.